FIORILLO, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 65
EU - Europa 61
AS - Asia 17
SA - Sud America 1
Totale 144
Nazione #
US - Stati Uniti d'America 63
IT - Italia 45
SG - Singapore 17
GB - Regno Unito 4
NL - Olanda 3
CA - Canada 2
DE - Germania 2
EE - Estonia 2
FI - Finlandia 2
RU - Federazione Russa 2
BR - Brasile 1
SE - Svezia 1
Totale 144
Città #
Chandler 10
Chicago 7
Singapore 6
Rome 5
Ashburn 4
Ercolano 4
London 4
Milan 4
Santa Clara 4
Afragola 2
Brescia 2
Carbonia 2
Lawrence 2
Princeton 2
San Nicola Manfredi 2
Turku 2
West Lafayette 2
Benevento 1
Boardman 1
Cosenza 1
Dallas 1
Montreal 1
Naples 1
New York 1
Nuremberg 1
Palermo 1
Parma 1
St Petersburg 1
Stockholm 1
São Paulo 1
Totale 77
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 58
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 33
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 31
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 14
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 11
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 8
Totale 155
Categoria #
all - tutte 1.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 0 0 0 2 0 1 1 1 0
2022/202327 4 4 0 2 3 2 0 0 8 1 2 1
2023/202438 15 2 6 1 2 6 0 0 0 0 3 3
2024/202585 7 3 0 5 11 23 7 3 7 4 15 0
Totale 155